Showing 1 - 4 results of 4 for search 'Xianzhong Cheng', query time: 0.03s Refine Results
  1. 1
    Olaparib in the therapy of advanced ovarian cancer: first real world experiences in safety and efficacy from China

    Olaparib in the therapy of advanced ovarian cancer: first real world experiences in safety and efficacy from China by Jing Ni, Xianzhong Cheng, Rui Zhou, Xia Xu, Wenwen Guo, Xiaoxiang Chen

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Tumor burden is a potential marker of PARP inhibitor effects in ovarian cancer: a head-to-head observational series

    Tumor burden is a potential marker of PARP inhibitor effects in ovarian cancer: a head-to-head observational series by Jing Ni, Rui Zhou, Xianzhong Cheng, Xia Xu, Wenwen Guo, Xiaoxiang Chen

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    The value of secondary neoadjuvant chemotherapy in platinum-sensitive recurrent ovarian cancer: a case-control study post GOG-0213 trial

    The value of secondary neoadjuvant chemotherapy in platinum-sensitive recurrent ovarian cancer: a case-control study post GOG-0213 trial by Hongyuan Gu, Rui Zhou, Jing Ni, Xia Xu, Xianzhong Cheng, Yan Li, Xiaoxiang Chen

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    The efficacy and safety of niraparib for ovarian cancer: a single-center observational study from China

    The efficacy and safety of niraparib for ovarian cancer: a single-center observational study from China by Jing Ni, Xianzhong Cheng, Qian Zhao, Zhiqin Dai, Xia Xu, Wenwen Guo, Hongyuan Gu, Rui Zhou, Yan Wang, Xiaoxiang Chen

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: